Cite

    Margherita Brindisi et al.. “Targeting clinically-relevant metallo-β-lactamases: from high-throughput docking to broad-spectrum inhibitors.” Journal of enzyme inhibition and medicinal chemistry, vol. 31, n.d., pp. 98–109. http://access.bl.uk/ark:/81055/vdc_100039384705.0x000019